Famor, Florenciq B.
HRN: 01-38-04 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/06/2022
CEFTRIAXONE 1G (VIAL)
12/06/2022
12/13/2022
IV
2g
OD
T/C Hepatic Enceph
Waiting Final Action
Indication: Empiric Type of Infection: Central Nervous SystemMultiple Infections (tick All Sites) Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes